Multi-purpose rapid test kit HIV new design
Rapid Test and Treat Dolutegravir Plus Lamivudine . 2019-5-10 · Primary Purpose: Treatment: Official Title: A Phase 3b Multi-center, Open Label, Single Arm, 52-week Study, Evaluating the Feasibility, Efficacy and Safety of Rapid Test and Treat Intervention in Newly Diagnosed HIV-1 Infected Adults Using a Fixed Dose Combination of Dolutegravir Plus Lamivudine (DOVATO) as a First Line Regimen ...
Get Price